This issue is a dedicated supplement published in addition to the regular issues of 'Digestive Diseases' focussing on one specific topic. 'Digestive Diseases' is a well-respected, international peer-reviewed journal in Gastroenterology. Supplement issues are included in the subscription.
Introduction; Dealing with Our 'In-Vironment': New Apects of
Inflammatory Bowel Disease Pathogenesis and Therapy: Rogler, G.; Genetic Risk
Factors in IBD: Impaired Control of the 'In-Vironment'?; Genes and
'In-Vironment': How Will Our Concepts on the Pathophysiology of Inflammatory
Bowel Disease Develop in the Future? Fiocchi, C.; IBD: The 'In-Vironment' out
of Control?; Inflammatory Bowel Disease: Dysfunction of Autophagy? Scharl,
M.; Rogler, G.; Environmental Factors and Their Impact on the Intestinal
Microbiota: A Role for Human Disease? Biedermann, L.; Rogler, G.; Environment
and 'In-Vironment'; Why and Where to Look in the Environment with Regard to
the Etiology of Inflammatory Bowel Disease: Bernstein, C.N.; Does Our Food
(Environment) Change Our Gut Microbiome ('In-Vironment'): A Potential Role
for Inflammatory Bowel Disease? de Wouters, T.; Dore, J.; Lepage, P.;
Danger-Associated Molecular Patterns and Inflammatory Bowel Disease: Is There
a Connection? Mueller, C.; Microparticles and Their Impact on Intestinal
Immunity: Becker, H.M.; Bertschinger, M.M.; Rogler, G.; Treatment Decisions
Made Easy: Do We Have the Disease Markers We Need?; Circulating Antibodies
against Bacterial Wall Products: Are There Arguments for Early
Immunosuppression? Rieder, F.; Kugathasan, S.; Clinical Risk Factors for
Complicated Disease: How Reliable Are They? Zallot, C.; Peyrin-Biroulet, L.;
Intestinal Absorption and Vitamin Levels: Is a New Focus Needed? Vavricka,
S.R.; Rogler, G.; Changing the 'In-Vironment' for Therapy; Specific
Probiotics or 'Fecal Transplantation': Kruis, W.; Mucosal Protection by
Phosphatidylcholine: Stremmel, W.; Ehehalt, R.; Staffer, S.; Stoffels, S.;
Mohr, A.; Karner, M.; Braun, A.; Topical Therapy: Gross, V.; The Risks and
Benefits of Early Immunosuppression and Biological Therapy: Sands, B.E.; The
Classical Immunosuppression: Overrated or Underused?; Deep Remission: A New
Concept? Colombel, J.-F.; Louis, E.; Peyrin-Biroulet, L.; Sandborn, W.J.;
Panaccione, R.; Methotrexate: Underused and Ignored? Herfarth, H.H.; Long,
M.D.; Isaacs, K.L.; Extended Abstract: Tacrolimus and Cyclosporine in
Inflammatory Bowel Disease: Stange, E.F.; Biologicals and Beyond; Biological
Treatment of Crohn's Disease: Nielsen, O.H.; Bjerrum, J.T.; Seidelin, J.B.;
Nyberg, C.; Ainsworth, M.; Stem Cells as Treatment in Inflammatory Bowel
Disease: Hawkey, C.J.; The Future of Inflammatory Bowel Disease Therapy:
Where Do We Go from Here? Sandborn, W.J.
